Sector portfolio · VC firm · China

Legend Capital's Biotech portfolio

Legend Capital has backed 24 Biotech startups in rounds we track, $1.8B between them, shown by the stage each has reached. The best-funded is Innovent Biologics.

24startups backed
4stages
$1.8Braised between them
Series Bbiggest stage

Legend Capital's whole portfolioLegend Capital's profile

Series B

11

Series C and later

8

Stage not reported

3

Pre-seed and seed

2

Segment by segment

Series B

11 startups · $809M raised

  1. Haihe BiopharmaHaihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.China$317M
  2. Harbour BioMedHarbour BioMed is a clinical stage biopharmaceutical company developing innovative therapeutics in the fields of immuno-oncology.China$190M
  3. EDEnjoy Dental ClinicChina$70M
  4. Medilink TherapeuticsMediLink Therapeutics, founded in 2020 and based in Suzhou, China, is a clinical-stage biotechnology company focused on developingChina$70M
  5. DdMedChina$50M
  6. BBellenChina$38M
  7. ColorTech BioColorTech Bio researches and develops precision molecular diagnostic equipment.China$24M
  8. YCYosemite ClinicYosemite Clinic is a full-service clinic providing convinient walk-in medical services in a state-of-the-art enviroment in Central Pudong.China$15M

Series C and later

8 startups · $984M raised

  1. Innovent BiologicsEstablished in 2011, Innovent is committed to developing, manufacturing and commercializing high quality innovative medicines for China$385M
  2. SCShanghai Cell TherapyChina$176M
  3. IInnoventHong Kong SAR China$150M
  4. New Horizon HealthNew Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.China$96M
  5. Shanghai Cell Therapy GroupShanghai Cell Therapy Group is an innovative company based in China, founded in 2013.China$77M
  6. Sciwind BiosciencesSciwind Biosciences is a drug research and development company for metabolic diseases.China$70M
  7. LYNK PharmaceuticalsLYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines.-$17M
  8. AAxionicsUnited States$15M

Stage not reported

3 startups · $32M raised

  1. ImmunochinaImmunochina Pharmaceuticals produces cell injections, cell therapy drugs, and other products and provides medical technology development.China$20M
  2. Berry GenomicsBerry Genomics is a Beijing-based company specializing in genomics and life sciences.China$10M
  3. SinglomicsSinglomics uses single-cell sequencing technology for antibody drug discovery.China$1.4M

Pre-seed and seed

2 startups · $24M raised

  1. LKLingtai Krypton BiotechnologyLingtai Krypton Biotechnology is an innovative corporation that specializes in the development of lncRNA drugs.-$14M
  2. N1 LifeN1 Life is a biotechnology research company based in Milpitas, California, founded in 2019 as a spinout from Stanford University.United States$10M

How this map is made. Every startup here works in Biotech and has raised money in a round we track that names Legend Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.

More portfolio maps

All portfolios
Sector portfolioLegend Capital's AI portfolio13 startups · $26BPortfolio mapLegend Capital portfolio map91 startups · $39BCo-investorsWho invests with Legend Capital53 co-investorsSector portfolioTengxun Touzi's AI portfolio42 startups · $42BSector portfolioLD Capital's Web3 & Crypto portfolio41 startups · $292MSector portfolioTengxun Touzi's Fintech portfolio35 startups · $10B

Raising from investors like Legend Capital?

Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.

Find investorsMarket maps